Oyster peptides for relieving ulcerative colitis: A combination of cell experiments and network pharmacology screening

Read full text Summarise with VIRAT
Authors: Si Li, Ru Li, Hua Chen, Deke Chen, Peng Wan, Weimao Zhong, Huili Sun, Jianyu Pan, Bingna Cai, Jun Li
Cited by: 0
References: 39

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Ulcerative colitis (UC), an inflammatory bowel disease, is characterized by inflammation and oxidative stress. Oyster, a high-nutrition mariculture shellfish, is a vital source of bioactive peptides. This study aimed to excavate oyster-derived peptides to alleviate dextran sulfate sodium (DSS)-induced UC. Combined cell assays and network pharmacology, it was found that both FR8 (FAGDDAPR) and GR9 (GFAGDDAPR) significantly alleviated DSS-induced NCM460 cell injury, enhanced viability, and exerted anti-inflammatory and antioxidant effects. At 1 μg/mL, FR8 reduced IL-6, TNF-α and ROS by 11.58 ± 3.08%, 21.52 ± 0.75% and 49.04 ± 0.82% respectively, and increased SOD activity by 41.62 ± 5.04%. While GR9 exerted corresponding effects of 12.10 ± 5.72%, 22.16 ± 1.05%, 50.56 ± 0.83%, and 41.41 ± 4.59%. Molecular dynamics simulations clarified their intermolecular interaction with caspase-1. These findings support FR8 and GR9 as UC-mitigating functional food ingredients, and provide a theoretical basis for high-value utilization of oyster peptide resources. • Two peptides from oyster inhibit oxidative stress and inflammation in NCM460 cells. • These two peptides may target and inhibit the activity of caspase-1. • They are potential functional food ingredients for ulcerative colitis management.

Fields of Study & Subjects

Protein Hydrolysis and Bioactive Peptides Inflammatory Bowel Disease Neuropeptides and Animal Physiology

Publication details

Journal / source
Journal of Functional Foods
Volume
140
Pages
107263–107263
Publication date
27 March 2026
Language
EN